The Management of Cancer Patients: Separate Research Experiences with Gemcitabine HCL and DAB389IL-2 Fusion Protein : Based on Scientific Proceedings of an Eli Lilly and Company Satellite Symposium at the 8th European Conference on Clinical Oncology and C
Card's contents:1 MANAGEMENT 312.098 The Management of Cancer Patients: Separate Research Experiences with Gemcitabine HCL and DAB389IL-2 Fusion Protein : Based on Scientific Proceedings of an Eli Lilly and Company Satellite Symposium at the 8th European Conference on Clinical Oncology and Cancer Nursing in Paris, 29 October-2 November 1995 / P.E. Postmus, guest ed.. -